GSK plc (GSK) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for GSK plc, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 6.45x | 21.39x | 12.13x | 3.91x | 11.90x | 9.33x |
| P/B Ratio | 2.25x | 4.03x | 3.51x | 5.52x | 2.56x | 2.69x |
| P/S Ratio | 1.13x | 1.76x | 1.97x | 1.99x | 2.11x | 2.20x |
| Profitability | ||||||
| Gross Margin | 72.4% | 71.2% | 71.8% | 67.4% | 66.9% | 67.4% |
| Operating Margin | 25.5% | 12.8% | 22.2% | 21.9% | 17.6% | 24.6% |
| Net Margin | 17.5% | 8.2% | 16.2% | 51.0% | 17.8% | 23.6% |
| EBITDA Margin | 31.8% | 21.3% | 29.9% | 29.3% | 26.3% | 33.1% |
| Liquidity | ||||||
| Current Ratio | 0.82x | 0.78x | 0.88x | 0.91x | 0.79x | 0.91x |
| Quick Ratio | 0.54x | 0.52x | 0.62x | 0.68x | 0.54x | 0.64x |
| Leverage | ||||||
| Debt/Equity | 1.08x | 1.24x | 1.35x | 1.98x | 1.61x | 1.86x |
YoY = year-over-year change. Source: FMP..